TP53 is the second most frequently mutated gene in breast cancer (23%) after PIK3CA (26%) [25] and is considered among the key driving factors in TNBC - the most aggressive breast cancer subgroup [26]. This evidence concerns the gene PIK3CA and breast carcinoma.